Related Experiment Video
Updated: May 21, 2026
05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Sentinel lymph node biopsy in penile carcinoma.
1Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. s.horenblas@nki.nl
Seminars in Diagnostic Pathology
|May 31, 2012
Summary
Sentinel lymph node (SLN) biopsy is a reliable method for staging penile cancer. This minimally invasive technique accurately detects lymph node spread, reducing treatment complications and preserving patient survival.
Area of Science:
- Oncology
- Surgical Pathology
- Nuclear Medicine
Background:
- Sentinel lymph node (SLN) biopsy is an emerging standard for regional lymph node staging in solid tumors.
- It relies on the principle of stepwise lymphatic metastasis.
- The SLN is the first node to receive lymphatic drainage from the tumor.
Purpose of the Study:
- To evaluate the efficacy and safety of SLN biopsy in penile cancer staging.
- To determine if SLN biopsy can replace traditional lymphadenectomy for penile cancer.
Main Methods:
- Preoperative lymphoscintigraphy using technetium-99m labeled colloid particles.
- Intradermal peritumoral tracer injection to identify the SLN.
- Surgical excision and pathological examination of the identified SLN.
Main Results:
- SLN biopsy demonstrated a low false-negative rate of 7%.
- The complication rate associated with SLN biopsy was less than 5%.
- SLN biopsy effectively detects lymph node invasion with minimal morbidity.
Conclusions:
- Sentinel lymph node biopsy is a highly reliable procedure for penile cancer.
- It enables early detection of lymph node metastasis.
- SLN biopsy significantly minimizes treatment-related morbidity compared to standard lymphadenectomy.